Pronađeno: 31-40 / 56 radova

Autori: Popovic Lazar S

>> Filter: Samo Article i Review

Naslov AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan) (Article)
Autori Todorovic Vladimir  ...  Babovic Nada Lj  ...  Cetnikovic Bojana  Ceric Timur  ...  Dzamic Zoran M  Dzodic Radan R  Eri Zivka  ...  Knezevic-Usaj Slavica F  Kovcin Vladimir N  ...  Markovic Ivan Z  Markovic Milan  Mijalkovic Nenad  ...  Pantelic Aleksandra  Popovic Lazar S  Radosavljevic Davorin Z  ...  Radulovic Sinisa S  ...  Rosic Ivana  ...  Stamatovic Ljiljana  ...  Tesanovic Dusanka D  Tomasevic Zorica I  Tomasevic Zoran M  ...  Vasovic Suzana  Vicko Ferenc  ...  Zaric Bojan  ...  (broj koautora 65) 
Info JOURNAL OF BUON, (2019), vol. 24 br. 5, str. 2180-2197
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial (Article)
Autori Tan Antoinette R  ...  Popovic Lazar S  ...  Milenkovic Dusan M  ...  (broj koautora 17) 
Info LANCET ONCOLOGY, (2019), vol. 20 br. 11, str. 1587-1601
Projekat G1 Therapeutics
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Trilaciclib improves overall survival when given with gemcitabine/carboplatin (GC) in patients with metastatic triple negative breast cancer (mTNBC) in a randomized phase II trial (Meeting Abstract)
Autori O'Shaughnessy J  ...  Popovic Lazar S  ...  Milenkovic Dusan M  ...  (broj koautora 17) 
Info ANNALS OF ONCOLOGY, (2019), vol. 30 br. , Suppl. 5, str. 860-+
Projekat G1 Therapeutics, Inc.
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Diffuse large B-cell lymphoma and prognostic significance of immunohistochemical antibodies VEGF and COX2 (Meeting Abstract)
Autori Nikin Zoran  Popovic Lazar S  Solajic Nenad S  Ivkovic-Kapicl Tatjana V  Knezevic-Usaj Slavica F  Panjkovic Milana 
Info VIRCHOWS ARCHIV, (2019), vol. 475 br. , Suppl. 1, str. S335-S335
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Trilaciclib (T), a CDK4/6 inhibitor, dosed with gemcitabine (G), carboplatin (C) in metastatic triple negative breast cancer (mTNBC) patients: Preliminary phase 2 results (Meeting Abstract)
Autori O'Shaughnessy J  ...  Popovic Lazar S  ...  Vojnovic Z  ...  Milenkovic D  ...  (broj koautora 23) 
Info CANCER RESEARCH, (2019), vol. 79 br. 4, Suppl. S, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Do we really know how to overcome trastuzumab resistance in hormone sensitive metastatic breast cancer? (Article)
Autori Cvetanovic Ana S  Pejcic Ivica  Zivkovic Nikola D  Krtinic Dane A  Kostic Milos S  Popovic Lazar S 
Info JOURNAL OF BUON, (2019), vol. 24 br. 2, str. 516-521
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Real world data: Trastuzumab w/o concurrent endocrine therapy in luminal HER2-positive metastatic breast cancer resulted in decreased overall survival (Meeting Abstract)
Autori Susnjar Snezana V  Popovic Lazar S  Cvetanovic Ana S  Stanic Nemanja S  Citic J  Kolarov-Bjelobrk Ivana N  Popovic Marina  Nedovic Nikola M  Stojanovic Aleksandar  Matovina-Brko Gorana G  Serovic Kristina  Milosavljevic N  Mutrezani Zafir  ...  Gavrilovic Dusica  Radulovic Sinisa S 
Info EUROPEAN JOURNAL OF CANCER, (2018), vol. 92 br. , Suppl. 3, str. S112-S112
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Ten years of using adjuvant trastuzumab in breast cancer in Serbia - Single institution experience (Article)
Autori Cvetanovic Ana S  Filipovic Sladjana  Zivkovic Nikola D  Popovic Lazar S  Kostic Milos S  Djordjevic Miodrag N  Karanikolic Aleksandar D  Krtinic Dane A 
Info JOURNAL OF BUON, (2018), vol. 23 br. 2, str. 353-360
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Rituximab in the therapy of stage III and IV follicular lymphoma: Results of the REFLECT 1 study of the Serbian Lymphoma Group (Article)
Autori Popovic Stevan L  Jovanovic Darjana  Mihaljevic Biljana S  Andjelkovic Nebojsa V  Marjanovic Goran T  Marisavljevic Dragomir Z  Vlaisavljevic Nada V  Popovic Lazar S  Salma Svetlana  Agic Danijela D  Milosevic Rajko A  Smiljanic Mihailo  Sretenovic Snezana  Djurdjevic Predrag M  Markovic Olivera B  Hajder Jelena  Govedarovic Nenad N 
Info JOURNAL OF BUON, (2017), vol. 22 br. 2, str. 487-494
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Ispis zapisa u formatu:TXT | BibTeX